Kevin J Klos MD

Movement Disorder

Founder of The Movement Disorder Clinic of Oklahoma

7134 S Yale AveSte 205Tulsa, OK 74136
Phone+1 918-392-4530
Fax+1 918-392-4535

Dr. Klos is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Klos' full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2001 - 2004
University of Virginia Medical CenterInternship, Internal Medicine, 2000 - 2001
University of Oklahoma College of MedicineClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OK State Medical License 2005 - 2027
KS State Medical License 2013 - 2016
MN State Medical License 2001 - 2006
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

74 citations
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C Warren Olanow, Dennis To
The Lancet. Neurology. 2024-01-01
16 citations
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HTAgonist, in Patients With Parkinson Disease Psychosis: A Pilot Study.
Stuart H Isaacson, Mark Goldstein, Rajesh Pahwa, Carlos Singer, Kevin Klos
Neurology. Clinical Practice. 2023-08-01
29 citations
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
Michael Camilleri, Thyagarajan Subramanian, Fernando Pagan, Stuart Isaacson, Ramon Gil
Annals of Internal Medicine. 2022-12-01